Publications

  1. Reversible malignant hypertension due to inferior vena cava thrombosis
    Journal of Post Graduate Medicine. 28 (4); 223-224; 1982.
  2. Lymphuria (A Case Report)
    Indian Journal of Surgery .Vol.44 (9);1982
  3. Xanthogranulomatous  pyelonephritis (Report  of two cases)
    Indian Journal  of Surgery. 45 (4). 1983
  4. Fatal Air Embolism following Retroperitoneal Air Insufflations
    Journal of Post Graduate Medicine.29 (3);191-2;1983 Jul.
  5. Oliguria and left upper limb weakness.
    Journal of Association of Physician of India. 31(8); 539-541;1983 Aug
  6. Hyperlipidemia in Patients with Chronic Renal Failure.
    Journal of Post graduate Medicine. 29 ( 4 ); 212-217;1983 Oct
  7. ASO Titre and Serum Complement ( C3 ) in Post Streptococcal Glomerulonephritis
    Journal of Post Graduate Medicine. 30 (1); 27-32; 1984 Jan
  8. Methyl Alcohol Poisoning – ( Experience of an out break in Bombay )
    Journal of Post Graduate Medicine. 30 ( 2 ); 69-74;1984 Apr
  9. Effect of Granulocyte Macrophage Colony Stimulating Factor on Hepatitis – B Vaccination in Haemodialysis patients.
    Journal of Association of Physician of India. 47(6): 602-604; 1999 Jun
  10. Ulnar basilic Arteriovenous Fistulae for Haemodialysis
    Dialysis & Transplantation .28(6):314-316; 1999 Jun
  11. Vegetarian diet in kidney failure .
    International Vegetarian Congress Journal – 2001
  12. Bone Densitometry in Post Renal Transplant Patients
    Indian Journal of Nephrology; 11:58-60; 2001
  13. 24-hours Ambulatory Blood Pressure ( ABP ) monitoring in Renal Transplant recipients
    Indian Journal of Nephrology .12(2); 47-51;2002.
  14. Intra Peritoneal Amikacin for treatment of Tuberculous Peritonitis in addition to oral drugs in CAPD patients – A report on two cases
    Indian Journal of Peritoneal Dialysis. 4:36-38; 2002
  15. Spontaneous Bilateral Perirenal Hematoma in a patient with Tetrology of Fallot.
    Nephron. 92(4):929-930;2002 Dec.
  16. Prevalence of Renovascular Abnormality in Patients undergoing Cardiac Catheteization
    Journal of Association of Physician of India.51: 175-177; 2003 Feb
  17. Efficacy and tolerability of Sevelamer in the treatment of hyperphosphatemia in Indian patients on dialysis.
    Indian Journal of Nephrology. 15(4):198-204; 2005
  18. Ribavirin therapy for Chikungunya arthritis
    The Journal of Infection in Developing Countries. 2(2):140-142; 2008
  19. Predictors of long-term survival on peritoneal dialysis in South India: a multicenter study
    Perit Dial Int. 30(1):29-34; 2010 Jan-Feb
  20. An Indian model for cost-effective CAPD with minimal man power and economic resources
    Nephrol Dial Transplant. 26(10):3089-91;2011 Oct
  21. A correlative study on Hepatitis C Virus load determined by Real Time Polymerase Chain Reaction with Serum Biomakers in patients with Renal disease
    Journal of Molecular Biomarkers & Diagnosis. 3(2):123;2012
  22. Optimization and application of subtype specific polymerase chain reaction for detection and identification of mixed subtypes of hepatitis C virus in patients with renal disease Journal of Virological Method. 2012
  23. Prevalence of masked hypertension among kidney donors
    Indian Journal of Nephrology. Vol 22 (5);398 ; Sep 2012
  24. ABO incompatible kidney transplantation – A single center experience
    Indian Journal of Transplantation. 6(4):103-106; Oct-Dec 2012 
    Abstract: 
    Aim/Objective: ABO incompatible kidney transplantations are getting popular all over the world. It is essential that such transplantations are carried out in our country also.
    Material and methods: Thirteen patients who had undergone ABO incompatible transplantations in a single center since 2009 were studied. The transplantations have been across different blood group combinations. The preconditioning of the patient was done as per the Japanese protocol.
    Results: The patients were followed up between 4 weeks to 28 months. Two patients had immediate antibody mediated rejection with loss of graft. The rest 11 patients have normal graft function without any complication.
    Conclusion: Successful ABO incompatible transplantation is feasible in our country without endangering the life of recipient with reasonable cost control. Further studies are required to modify the protocol to prevent immediate antibody-mediated rejections (ABMR).
  25. Forearm Bone Mineral Density of Normal Indian Population
    Open Access Library Journal. Volume 1:e691; August 2014
  26. ABO Incompatible Kidney Transplantation- A review with a perspective from a center in India
    International Journal of Pharmaceutical and Medicinal Research, 2015; 3(6):288-291
    Abstract:
    ABO incompatible kidney transplantation is performed all over the world in order to increase the donor pool and reduce the waiting time for kidney transplantation. The success of such transplantation depends on the desensitization at the time of transplantation. Although in the immediate post operative period more antibody mediated rejections are seen the long term outcome is excellent comparable to the regular kidney transplantation. In a country like India, infections are a major problem related to excessive immunosupression. This article describes the present state of art in ABO incompatible kidney transplantations and the experience of a center from South India where 35 patients have undergone such transplantation. 
  27. Long Term Follow-Up of ABO Incompatible Kidney Transplantation—A Study from India
    Open Access Library Journal, 3: e2544. March 2016
    Abstract:
    Background: There is a need to do ABO incompatible kidney transplantation in a country like India where deceased donor transplantation is not common. More than 90% transplantations are done with living donors. Although short term results have been reported from 4 centers, there is paucity of data on long term follow-up of such patients. Methods: The data of 18 patients who had undergone ABO incompatible transplantation exceeding a follow-up of 12 months up to 66 months were analyzed. It was compared with the data of compatible kidney transplantation during the same period. Results: In both the groups, there was a similar incidence of urinary tract infection and gastroenteritis with complete recovery. Tuberculosis was successfully treated in 2 patients who had undergone ABO incompatible transplantation. The graft function was excellent with an average follow-up period of 38.2 months. There was no patient mortality during the follow-up period. Conclusion: The long term outcome of ABO incompatible kidney transplantation is similar to compatible kidney transplantation despite the increased incidence of short term complications. 
  28. Treatment efficacy and tolerability of Sofosbuvir and Ribavirin for chronic hepatitis C infection in post renal transplant patients – A retrospective single centre study
    Indian Journal of Transplantation, June 2016
  29. Cystinosis: a truly orphan disease. Report of the Cystinosis Foundation India.
    Rare diseases and orphan drugs, Vol. 3, No.1 (2016)
  30. Molecular Analysis of the CTNS Gene in Indians with Nephropathic Cystinosis
    The Indian Journal of Pediatrics. Nov 2016
  31. Complications of ABO incompatible Kidney Transplantation
    ECAB Clinical Update: Nephrology. ELSEVIER India. Page 131-142. 2016
    Abstract:
     
    ABO incompatible kidney transplantation (ABOi KT) is getting increasingly popular all over the world in order to increase the living donor pool. Since the process involves desensitization one to four weeks prior to transplantation and increased immunosuppression at least for the first two weeks, the complications are higher than the regular kidney transplantation. The major complications include increased incidence of Antibody Mediated Rejection (ABMR), bleeding and infections. These complications are seen more in the early post operative period rather than in the long term. The complications can start even before transplantation since the protocol of desensitization includes plasmapheresis (PE) and immunosuppression well before the transplantation. A national database study from the US reported in 2013 the early complications of ABOi KT between the years 2000 to 2007 [1]. Unadjusted complication frequencies at 90 days after transplantation in the ABO incompatible (ABOi) recipients were significantly high for hemmorrage (13%), wound infections (12.1%), pneumonia (7.3%) and urinary tract infection (UTI) (34.1%). The corresponding figures for ABO compatible (ABOc) recipients were 6.7%, 7.3%, 3.8% and 22.2% respectively (Table 1). The complications were not significantly different between 91 to 365 days.
  32. Education and screening for chronic kidney disease in Indian youth: pilot program results
    Int J Nephrol Renovasc Dis. 2017; 10: 85–90. Published online 2017 Apr 24. doi:  10.2147/IJNRD.S128417
  33. Microbiology, Clinical Spectrum and Outcome of Peritonitis in Patients Undergoing Peritoneal Dialysis in India: Results from a Multicentric, Observational Study
    Indian J Med Microbiol 2017;35:491-8